← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

M 10b5-1 Plan

$ Value

$0

Shares

6,000

Price

$0

Filed

Oct 16

Insider

Name

HUSSAIN IQBAL J

Title

General Counsel

CIK

0001862050

Roles

Officer

Transaction Details

Transaction Date

2025-10-15

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

227,559

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.29 to $22.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | 25% of the shares subject to such option shall vest and become exercisable on February 19, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.

Filing Info

Accession No.

0001470831-25-000263

Form Type

4

Issuer CIK

0001847903

HUSSAIN IQBAL J's History

Date Ticker Type Value
2026-02-02 CNTA $980K
2026-02-02 CNTA A $0
2026-02-02 CNTA A $0
2026-02-02 CNTA A $0
2026-02-01 CNTA F $191K
2026-01-30 CNTA $25K
2025-11-17 CNTA M $35K
2025-11-17 CNTA $166K
2025-11-17 CNTA M $0
2025-10-15 CNTA M $35K

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Kanes Stephen
Chief Medical Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$6.5M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02